ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $313,000 | +4.3% | 290,000 | 0.0% | 0.16% | -4.8% |
| Q3 2020 | $300,000 | -30.2% | 290,000 | -25.6% | 0.17% | -25.2% |
| Q2 2020 | $430,000 | -13.7% | 390,000 | -20.4% | 0.22% | -28.8% |
| Q1 2020 | $498,000 | -13.8% | 490,000 | -3.0% | 0.31% | +13.5% |
| Q4 2019 | $578,000 | -1.9% | 505,000 | -1.9% | 0.28% | -37.4% |
| Q3 2019 | $589,000 | -8.4% | 515,000 | +8.4% | 0.44% | -26.8% |
| Q2 2019 | $643,000 | +2.1% | 475,000 | +2.2% | 0.60% | +50.4% |
| Q1 2019 | $630,000 | +15.4% | 465,000 | -8.8% | 0.40% | -6.1% |
| Q4 2018 | $546,000 | +1.7% | 510,000 | 0.0% | 0.42% | +18.1% |
| Q3 2018 | $537,000 | -4.3% | 510,000 | -10.5% | 0.36% | +18.0% |
| Q2 2018 | $561,000 | +1.1% | 570,000 | +1.8% | 0.30% | -14.3% |
| Q1 2018 | $555,000 | – | 560,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |